Related Experiment Video
Updated: May 12, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between cystatin C and arteriosclerosis in the absence of chronic kidney disease
Hiroshi Yamashita1, Tomoya Nishino, Yoko Obata
1Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan.
Insights
This study found that serum cystatin C levels correlate with cardio-ankle vascular index (CAVI), an early arteriosclerosis marker, in women without chronic kidney disease (CKD). This suggests cystatin C may predict vascular changes even in individuals with normal kidney function.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Chronic kidney disease (CKD) is a known risk factor for cardiovascular disease (CVD).
- Serum cystatin C is an emerging marker of kidney function and a predictor of CVD.
- The relationship between cystatin C and arteriosclerosis in individuals without CKD is not well understood.
Purpose of the Study:
- To investigate the association between serum cystatin C levels and markers of arteriosclerosis in a population without CKD.
- To determine if cystatin C can predict early vascular changes in individuals with preserved kidney function.
Main Methods:
- Analysis of 446 Japanese adults (eGFR >60 mL/min, no proteinuria, no history of CVD).
- Kidney function assessed by serum cystatin C and estimated glomerular filtration rate (eGFR).
- Arteriosclerosis evaluated using cardio-ankle vascular index (CAVI) and carotid intima-media thickness (CIMT).
Main Results:
- A significant correlation was found between serum cystatin C and CAVI in women.
- No significant correlation was observed between serum cystatin C and CIMT in either gender.
- No significant differences in variables were noted based on gender.
Conclusions:
- Serum cystatin C is significantly associated with CAVI, a marker of early arteriosclerosis, in women without CKD.
- These findings suggest cystatin C may serve as a predictor of vascular damage in individuals with normal kidney function.
- Further research is warranted to explore the clinical implications of these findings.
Aim:
Chronic kidney disease (CKD) is a known risk factor for cardiovascular disease (CVD). Cystatin C was recently reported to be an endogenous surrogate of kidney function, and a high level of cystatin C is reported to be a strong predictor of CVD; however, the association between cystatin C and arteriosclerosis in a non-CKD population is unclear. This study aimed to clarify the association between cystatin C and arteriosclerosis in a non-CKD population.
Methods:
Of the 637 Japanese adults (264 men, 373 women) enrolled, we analyzed 446 participants with an estimated glomerular filtration rate (eGFR) >60 mL/min and no proteinuria (177 men, 269 women) without a history of CVD. Kidney function was evaluated according to serum cystatin C levels and eGFR. Arteriosclerosis was evaluated on the basis of the cardio-ankle vascular index (CAVI) and carotid intima-media thickness (CIMT).
Results:
The mean age of our subjects was 67.0±10.0 years. No variables showed any significant differences according to gender. The results of multiple linear regression analysis showed a significant correlation between serum cystatin C and CAVI only in women, but not CIMT.
Conclusion:
We observed a significant correlation between cystatin C and CAVI, which is a marker of early-stage arteriosclerosis, in women in a non-CKD population with no proteinuria and eGFR>60 mL/min.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Urinary Tract Calculi I: Introduction
Coronary Artery Disease I: Introduction
